Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Exploratory study of hepatitis D virus infection in HBsAg carriers in Abidjan, Cte Divoire in 2016

Autor: Kouassi M’Bengue, Doumbia Moussa, Djehiffe Vicky, Mireille Dosso, Sevede Daouda, Kouakou Viviane

Publikováno v: African Journal of Microbiology Research. 12:488-491

In sub-Saharan Africa, the prevalence of co-infection with hepatitis D (HDV) and hepatitis B viruses (HBV) is poorly known. Chronic infection with HBV is currently treated by nucleoside analogs whereas interferon is used to inhibit HDV. Nevertheless,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5c543f55b6d2f8772f3c9606c6819550
https://doi.org/10.5897/ajmr2017.8729

A very high frequency of hepatitis B and C virus infections during an active screening campaign in Abidjan

Autor: Mireille Dosso, Ouattara Abdoulaye, Doumbia Moussa, Sevede Daouda, Allah-Kouadio Emile, A Kouassi-M’Bengue

Publikováno v: African Journal of Microbiology Research. 11:8-15

Viral hepatitis is a serious public health problem affecting billions of people globally. Limited information is available on this issue in Cote d’Ivoire. The objectives of this study were to determine the prevalence and factors associated with hep

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa99d75a713bac38aa1217704eb47206
https://doi.org/10.5897/ajmr2016.8384

Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in two African settings: Lubumbashi, Democratic Republic of the Congo and Abidjan, Côte d'Ivoire.

Autor: Simons E; Epicentre, Paris, France., Nikolay B; Epicentre, Paris, France., Ouedraogo P; Epicentre, Paris, France., Pasquier E; Epicentre, Paris, France., Tiemeni C; Médecins Sans Frontières, Paris, France., Adjaho I; Médecins Sans Frontières, Abidjan, Cote d'Ivoire., Badjo C; Médecins Sans Frontières, Abidjan, Cote d'Ivoire., Chamman K; Epicentre, Paris, France., Diomandé M; Médecins Sans Frontières, Abidjan, Cote d'Ivoire., Dosso M; Institut Pasteur Cote d'Ivoire, Abidjan, Cote d'Ivoire., Doumbia M; Institut Pasteur Cote d'Ivoire, Abidjan, Cote d'Ivoire., Izia YA; Médecins Sans Frontières, Paris, France., Kakompe H; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Katsomya AM; Médecins Sans Frontières, Paris, France., Kij V; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Akissi VK; Institut Pasteur Cote d'Ivoire, Abidjan, Cote d'Ivoire., Mambula C; Médecins Sans Frontières, Paris, France., Mbala-Kingebeni P; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo., Muzinga J; Laboratoire National de Lubumbashi, Lubumbashi, Democratic Republic of the Congo., Ngoy B; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Penali L; Institut Pasteur Cote d'Ivoire, Abidjan, Cote d'Ivoire., Pini A; Epicentre, Paris, France., Porten K; Epicentre, Paris, France., Salou H; Epicentre, Paris, France., Sevede D; Institut Pasteur Cote d'Ivoire, Abidjan, Cote d'Ivoire., Luquero F; Epicentre, Paris, France., Gignoux E; Epicentre, Paris, France.

Publikováno v: PLOS global public health [PLOS Glob Public Health] 2023 Jun 08; Vol. 3 (6), pp. e0001457. Date of Electronic Publication: 2023 Jun 08 (Print Publication: 2023).